Scilex Holding Co Sustainability Reports

Scilex Holding Company is a commercial-stage biopharmaceutical company focused on acquiring, developing, and commercializing non-opioid pain management products.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900SPEA2C7YTTYP45

FIGI: BBG00YJTT5F2

4 reports from 2022 to 2025

• Scilex Holding Co 2025 Annual Report on Form 10-K
• Scilex Holding Co 2023 Annual Report on Form 10-K
• Scilex Holding Co 2023 Sustainability Report
• Scilex Holding Co 2022 Annual Report on Form 10-K